v3.26.1
Basis of Presentation (Details) - DiamiR Biosciences Corp. [Member]
6 Months Ended 12 Months Ended
Nov. 30, 2025
USD ($)
Nov. 30, 2024
USD ($)
May 31, 2025
USD ($)
May 31, 2024
USD ($)
Basis of Presentation [Line Items]        
Business segment unit 1      
Net loss $ (409,955)   $ (743,235) $ (614,405)
Net cash used in operating activities $ (215,008) $ (145,861) (313,440) (308,914)
Limited Operating [Member]        
Basis of Presentation [Line Items]        
Net loss     (743,235) $ (614,405)
Net cash used in operating activities     $ (313,440)